Micro-Tech (Nanjing) Co., Ltd.

Shanghai Stock Exchange 688029.SS

Micro-Tech (Nanjing) Co., Ltd. Revenue for the year ending December 31, 2023: USD 339.66 M

Micro-Tech (Nanjing) Co., Ltd. Revenue is USD 339.66 M for the year ending December 31, 2023, a 18.37% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Micro-Tech (Nanjing) Co., Ltd. Revenue for the year ending December 31, 2022 was USD 286.94 M, a -6.34% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Revenue for the year ending December 31, 2021 was USD 306.38 M, a 50.77% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Revenue for the year ending December 31, 2020 was USD 203.21 M, a 8.23% change year over year.
Micro-Tech (Nanjing) Co., Ltd. Revenue for the year ending December 31, 2019 was USD 187.75 M, a 40.04% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 688029.SS

Micro-Tech (Nanjing) Co., Ltd.

CEO	Mr. Feng Zhang
IPO Date	July 22, 2019
Location	China
Headquarters	No. 10, Gaoke Third Road
Employees	2,404
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Micro-Tech (Nanjing) Co., Ltd. manufactures and sells non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, Oceania, etc. The company offers gastroenterology products, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, cytology brushes, retrieval devices, and accessories. The company also offers OEM/ODM services to companies in the medical devices field. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.

Key trends

Past 5 years